Abstract
Patients with conditions affecting the perianal skin present to various clinics, from proctology to sexual health to general practice. The boundaries of such specialties as dermatology, infectious disease and gastrointestinal surgery are crossed by the range of diagnoses that underlie complaints in the perianal region. The problem may be local to the area, be an indication of intestinal disease or represent a manifestation of a generalized dermatological disorder. In the latter case, it is notable that the moist and warm environment of the perianal region often produces differing appearances to those characteristic of the disease elsewhere.
The perianal region is a common site for presentation of sexually transmitted infections, which are addressed in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Phillips R, Brown T. Surgical management of anal incontinence Part A: secondary anal sphincter repair. In: Sultan A, Thakar A, Fenner D, editors. Perineal and anal sphincter trauma. London: Springer; 2007. p. 144–53.
Dodi G, Pirone E, Bettin A, et al. The mycotic flora in proctological patients with and without pruritus ani. Br J Surg. 1985;72(12):967–9.
Schug S, Raajkumar A. Local anesthetics. In: Aronson J, editor. Meyler’s side effects of drugs used in anesthesia. Amsterdam: Elsevier; 2008. p. 152–63.
Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Nonfistulizing perianal Crohn’s disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis. 2010;16(8):1431–42.
Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2):205–17.
Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behavior in the United States: results from a national probability sample of men and women ages 14–94. J Sex Med. 2010;7 Suppl 5:255–65.
Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358(9296):1835–42.
Fornasa CV, Trento A, Bezze G. Pruritus ani: etiologic and causative factors in 94 adult patients. Pelviperineology. 2007;26(4):178–9.
Schnuch A, Carlsen B. Genetics and individual predispositions. In: Johansen J, Frosch P, Lepoittevin J, editors. Contact dermatitis. New York: Springer; 2010. p. 13–42.
Veien N. Clinical features. In: Johansen J, Frosch P, Lepoittevin J, editors. Contact dermatitis. New York: Springer; 2010. p. 255–303.
Bauer A, Geier J, Elsner P. Allergic contact dermatitis in patients with anogenital complaints. J Reprod Med. 2000;45(8):649–54.
Kugler K, Brinkmeier T, Frosch PJ, Uter W. Anogenital dermatoses–allergic and irritative causative factors. Analysis of IVDK data and review of the literature. J Dtsch Dermatol Ges. 2005;3(12):979–86.
Lazzarini R, Duarte I, de Farias DC, Santos CA, Tsai AI. Frequency and main sites of allergic contact dermatitis caused by nail varnish. Dermatitis. 2008;19(6):319–22.
Gardner KH, Davis MD, Richardson DM, Pittelkow MR. The hazards of moist toilet paper: allergy to the preservative methylchloroisothiazolinone/methylisothiazolinone. Arch Dermatol. 2010;146(8):886–90.
Vermaat H, Smienk F, Rustemeyer T, Bruynzeel DP, Kirtschig G. Anogenital allergic contact dermatitis, the role of spices and flavour allergy. Contact Dermatitis. 2008;59(4):233–7.
Warshaw EM, Furda LM, Maibach HI, et al. Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994–2004. Arch Dermatol. 2008;144(6):749–55.
British HIV Association, British Association of Sexual Health and HIV, British Infection Society. UK national guidelines for HIV testing, 2008. London: BHIVA/BASHH/BIS; 2008.
Virgili A, Bacilieri S, Corazza M. Evaluation of contact sensitization in vulvar lichen simplex chronicus.J Reprod Med 2003:48:33–6.
Crone AM, Stewart EJ, Wojnarowska F, Powell SM. Aetiological factors in vulvar dermatitis. J Eur Acad DermatolVenereol 2000:14:181–6.
Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362(9378):118–23.
Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev. 2012;(2):CD008092.
Abstracts from “Directions 2006: The First International Hidradenitis Suppurativa Research Symposium”. Exp Dermatol. 2006;15:478. doi: 10.1111/j.0906-6705.2006.0436a.x
Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142(5):947–53.
Plewig G, Kligman A. Acne: morphogenesis and treatment. Berlin: Springer; 1975.
Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989;298(6665):28–9.
Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery. New York: Marcel Dekker; 1989.
Mortimer PS, Lunniss PJ. Hidradenitis suppurativa. J R Soc Med. 2000;93(8):420–2.
Brocard A, Knol AC, Khammari A, Dreno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214(4):325–7.
Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36–40.
Rambhatla PV, Lim HW, Hamzavi I. A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol. 2012;148(4):439–46. doi: 10.1001/archdermatol.2011.1950. Epub 2011 Dec 19.
van Rappard DC, Limpens J, Mekkes JR. The off-label treatment of severe hidradenitis suppurativa with TNF-alpha inhibitors: a systematic review. J Dermatolog Treat. 2013;24(5):392–404. doi: 10.3109/09546634.2012.674193. Epub 2012 Apr 12.
Eglinton TW, Roberts R, Pearson J, Barclay M, Merriman TR, Frizelle FA, Gearry RB. Clinical and genetic risk factors for perianal Crohn’s disease in a population-based cohort. Am J Gastroenterol. 2011. doi:10.1038/ajg.2011.437.
Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. 2005;241(5):796–801; discussion 801–2.
Peyrin-Biroulet L, Loftus Jr EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Perianal Crohn’s disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis. 2012;18(1):43–8.
Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125(5):1508–30.
Peyrin-Biroulet L, Loftus Jr EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Perianal Crohn’s disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis. 2011;18(1):43–8.
Hughes LE. Surgical pathology and management of anorectal Crohn’s disease. J R Soc Med. 1978;71(9):644–51.
Irvine EJ. Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995;20(1):27–32.
Mahadev S, Young JM, Selby W, Solomon MJ. Self-reported depressive symptoms and suicidal feelings in perianal Crohn’s disease. Colorectal Dis. 2012;14(3):331–5.
Ingle SB, Loftus Jr EV. The natural history of perianal Crohn’s disease. Dig Liver Dis. 2007;39(10):963–9.
Williams DR, Coller JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn’s disease. Dis Colon Rectum. 1981;24(1):22–4.
Fleshner PR, Schoetz Jr DJ, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Anal fissure in Crohn’s disease: a plea for aggressive management. Dis Colon Rectum. 1995;38(11):1137–43.
Lozynskyy YS. Treatment algorithms in the case of perianal complications of Crohn’s disease. Dig Dis. 2009;27(4):565–70.
Siproudhis L, Mortaji A, Mary JY, Juguet F, Bretagne JF, Gosselin M. Anal lesions: any significant prognosis in Crohn’s disease? Eur J Gastroenterol Hepatol. 1997;9(3):239–43.
Nivatvongs S, Gordon P. Crohn’s Disease. In: Nivatvongs S, Gordon P, editors. Principles and practice of surgery for the colon, rectum, and anus. 3rd ed. New York: Informa Healthcare; 2007. p. 819–908.
Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease. Int J Colorectal Dis. 1993;8(3):117–9.
Lee RG. The colitis of Behcet’s syndrome. Am J Surg Pathol. 1986;10(12):888–93.
Burgess NA, Lari JL. Pyoderma gangrenosum with large circumferential perianal skin loss in a child. Br J Clin Pract. 1991;45(3):223–4.
Habr-Gama A, Sobrado CW, de Araujo SE, et al. Surgical treatment of anal stenosis: assessment of 77 anoplasties. Clinics (Sao Paulo). 2005;60(1):17–20.
Stein E. Perianal pigmentary disorders. In: Stein E. Anorectal and Colon Diseases. Berlin, Heidelberg: Springer-Verlag; 2003. pp 121–7.
Greenspon J, Williams SB, Young HA, Orkin BA. Thrombosed external hemorrhoids: outcome after conservative or surgical management. Dis Colon Rectum. 2004;47(9):1493–8.
Akbar F, Maw A, Bhowmick A. Anal ulceration induced by nicorandil. BMJ. 2007;335(7626):936–7.
Simms I, Bell G, Hughes G. Infectious syphilis in young heterosexuals: responding to an evolving epidemic. Int J STD AIDS. 2011;22(9):481–2.
White JA. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis. 2009;22(1):57–66.
Singhrao T, Higham E, French P. Lymphogranuloma venereum presenting as perianal ulceration: an emerging clinical presentation? Sex Transm Infect. 2011;87(2):123–4.
Sethi G, Allason-Jones E, Richens J, et al. Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome in men who have sex with men in London, UK. Sex Transm Infect. 2009;85(3):165–70.
Soni S, Srirajaskanthan R, Lucas SB, Alexander S, Wong T, White JA. Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men. Aliment Pharmacol Ther. 2010;32(1):59–65.
Hoie S, Knudsen LS, Gerstoft J. Lymphogranuloma venereum proctitis: a differential diagnose to inflammatory bowel disease. Scand J Gastroenterol. 2010;46(4):503–10.
Lewis DA. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect. 2003;79(1):68–71.
O’Farrell N, Moi H, IUSTI/WHO European STD guidelines Editorial Board. European guideline for the management of donovanosis, 2010. Int J STD AIDS. 2010;21(9):609–10.
Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805–12, A.
Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004;11 Suppl 1:2A–2323.
Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):305–10.
Sissons JGP. Oxford Textbook of Medicine. Chapter 7.5.2 Herpesviruses (excluding Epstein Barr virus). In: Warrell DA, Cox TM, Firth JD, editors. 5th ed. Oxford, New York: Oxford University Press; 2011. Accessed 9/2/2012.
Tyring SK, Carlton SS, Evans T. Herpes. Atypical clinical manifestations. Dermatol Clin. 1998;16(4):783–8, xiii.
Winer R, Koutsky LA. Genital human papillomavirus infections. In: Holmes KK, Sparling P, Stamm W, editors. Sexually transmitted infections. 4th ed. New York: McGraw-Hill; 2007.
Pattman R. Oxford handbook of genitourinary medicine, HIV, and sexual health. 2nd ed. Oxford ; New York: Oxford University Press; 2010.
Sonnex C, Scholefield JH, Kocjan G, et al. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. BMJ. 1991;303(6812):1243.
Martin JM, Molina I, Monteagudo C, Marti N, Lopez V, Jorda E. Buschke-Lowenstein tumor. J Dermatol Case Rep. 2008;2(4):60–2.
Oon SF, Winter DC. Perianal condylomas, anal squamous intraepithelial neoplasms and screening: a review of the literature. J Med Screen. 2010;17(1):44–9.
Future I II Study Group, Dillner J, Kjaer SK, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010;341:c3493.
Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365(17):1576–85.
Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87(7):544–7.
Brown M, Paulson C, Henry SL. Treatment for anogenital molluscum contagiosum. Am Fam Physician. 2009;80(8):864.
Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol. 2003;4(10):669–80.
Ranu H, Lee J, Chio M, Sen P. Tumour-like presentations of anogenital herpes simplex in HIV-positive patients. Int J STD AIDS. 2011;22(4):181–6.
Lawn SD, Meintjes G. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther. 2011;9(4):415–30.
Couppie P, Sarazin F, Clyti E, et al. Increased incidence of genital herpes after HAART initiation: a frequent presentation of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients. AIDS Patient Care STDS. 2006;20(3):143–5.
Tognetti L, Martinelli C, Berti S, et al. Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists. J Eur Acad Dermatol Venereol. 2012;26:931–41.
Hay R. Oxford Textbook of Medicine. Chapter 23.10 Infections and the skin. In: Warrell DA, Cox TM, Firth JD, editors. 5th ed. Oxford: Oxford University Press; 2011. Accessed 9/2/2012.
Holdiness MR. Management of cutaneous erythrasma. Drugs. 2002;62(8):1131–41.
Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2007;25(2):173–80.
Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011;343:d6099.
Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain. 2008;9(1 Suppl 1):S3–9.
Recondo G, Sella A, Ro JY, Dexeus FH, Amato R, Kilbourn R. Perianal ulcer in disseminated histoplasmosis. South Med J. 1991;84(7):931–2.
Ricciardi R, Alavi K, Filice GA, Heilly SD, Spencer MP. Blastomyces dermatitidis of the perianal skin: report of a case. Dis Colon Rectum. 2007;50(1):118–21.
Stanley Jr SL. Amoebiasis. Lancet. 2003;361(9362):1025–34.
Ganesh S, Cruz Jr RJ. Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (N Y). 2011;7(3):194–6.
Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368(9541):1106–18.
Georghiou PR, Tilse MH, McCormack JG, Neely MG. Fistula-in-ano: an unusual presentation of chronic schistosomiasis. Aust N Z J Surg. 1995;65(7):541–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Cuming, T., Bailey, A.C., Sashidharan, P.N. (2014). Perianal Skin Conditions. In: Cohen, R., Windsor, A. (eds) Anus. Springer, London. https://doi.org/10.1007/978-1-84882-091-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-84882-091-3_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-090-6
Online ISBN: 978-1-84882-091-3
eBook Packages: MedicineMedicine (R0)